Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
-
B. Braun Receives FDA Approval to Offer Broad Spectrum Intravenous Antibiotic-Meropenem, in Its Innovative DUPLEX Container – Courtesy (Market Watch)
Pharma Live, , Regulatory Affairs, 0
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced that it received U.S. Food...
-
A paradigm shift in Drug Regulatory in Taiwan!
Pharma Live, , Regulatory Affairs, 0
About Authors:*Parasiya Sachin kumar R., Balamuralidhara V., Pramod Kumar T.M., Rohit Gujarati, Abhisek Shukla, Vandana KshatriPharmaceutical Regulatory Affairs Group,...
-
MHRA Guide for Labeling and Packaging
Pharma Live, , Regulatory Affairs, 0
MHRA guide for labeling and packaging
-
European Medicines Agency and United States Food and Drug Administration to share manufacturing site inspections
Pharma Live, , Regulatory Affairs, 0
The European Medicines Agency and the United States Food and Drug Administration (FDA) are launching an initiative to share...
-
-
A REVIEW ON GOOD MANUFACTURING PRACTICE (GMP) FOR MEDICINAL PRODUCTS
Pharma Live, , Regulatory Affairs, 0
ABOUT AUTHORS:Vikash Kumar Chaudhari1*, Vijay Yadav2, Praveen Kumar Verma1, Amit Kumar Singh21Department of Pharmaceutical Chemistry,2Department of Pharmacognosy,Kunwar Haribansh Singh...
-
Channel strategy and orphan drugs – Courtesy (PMLiVe)
Pharma Live, , Regulatory Affairs, 0
A channel strategy is a plan for guiding decisions about a product’s distribution channel, ie the chain of intermediaries...
-
The moving parts of orphan drug development – Courtesy (PMLiVe)
Pharma Live, , Regulatory Affairs, 0
The very mention of orphan drugs is enough to give some pharma accountants the jitters. Chasing a cure for...
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)